Therapeutic Liquid Formulations Based on Low Transition Temperature Mixtures for the Incorporation of Anti-Inflammatory Drugs

Most nonsteroidal anti-inflammatory drugs (NSAIDs) present poor aqueous solubility, impairing their efficiency in physiological media. In this context, Low Transition Temperature Mixtures (LTTMs) are a promising platform to overcome drugs’ poor solubility, forming therapeutic liquid formulations. In...

Full description

Bibliographic Details
Main Authors: Ana Roda, Alexandre Paiva, Ana Rita C. Duarte
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/10/1620
_version_ 1797513412532502528
author Ana Roda
Alexandre Paiva
Ana Rita C. Duarte
author_facet Ana Roda
Alexandre Paiva
Ana Rita C. Duarte
author_sort Ana Roda
collection DOAJ
description Most nonsteroidal anti-inflammatory drugs (NSAIDs) present poor aqueous solubility, impairing their efficiency in physiological media. In this context, Low Transition Temperature Mixtures (LTTMs) are a promising platform to overcome drugs’ poor solubility, forming therapeutic liquid formulations. In this work, the LTTMs of citric acid:L-arginine:water (C:A:W) and glycerol:sorbitol (G:S) were studied in terms of their features and assessed in terms of their ability to increase the solubility of six NSAIDs in physiological media. The physicochemical properties of LTTMs were characterized by state-of-art techniques commonly used for these systems. The cytotoxicity of G:S was also evaluated in L929 mouse fibroblasts and the viscosity, polarity, and pH properties of the studied mixtures were related to the solubility of NSAIDs. The pH and polarity were the parameters that most influenced the drugs’ solubility. Ibuprofen, naproxen, ketoprofen, indomethacin, and flurbiprofen did not present any solubility improvement in the formulations tested. However, concentrated mixtures of C:A:W or G:S in the physiologic-mimicked media (PBS) rendered a celecoxib solubility 4 and 5 times higher than PBS, respectively. These therapeutic liquid formulations of celecoxib in C:A:W or G:S can be a promising tool to increase celecoxib’s therapeutic efficiency in local applications.
first_indexed 2024-03-10T06:16:14Z
format Article
id doaj.art-637d1326eb1543178af55ab7512e384e
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T06:16:14Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-637d1326eb1543178af55ab7512e384e2023-11-22T19:38:38ZengMDPI AGPharmaceutics1999-49232021-10-011310162010.3390/pharmaceutics13101620Therapeutic Liquid Formulations Based on Low Transition Temperature Mixtures for the Incorporation of Anti-Inflammatory DrugsAna Roda0Alexandre Paiva1Ana Rita C. Duarte2LAQV, REQUIMTE, Chemistry Department, NOVA School of Science and Technology, 2829-516 Caparica, PortugalLAQV, REQUIMTE, Chemistry Department, NOVA School of Science and Technology, 2829-516 Caparica, PortugalLAQV, REQUIMTE, Chemistry Department, NOVA School of Science and Technology, 2829-516 Caparica, PortugalMost nonsteroidal anti-inflammatory drugs (NSAIDs) present poor aqueous solubility, impairing their efficiency in physiological media. In this context, Low Transition Temperature Mixtures (LTTMs) are a promising platform to overcome drugs’ poor solubility, forming therapeutic liquid formulations. In this work, the LTTMs of citric acid:L-arginine:water (C:A:W) and glycerol:sorbitol (G:S) were studied in terms of their features and assessed in terms of their ability to increase the solubility of six NSAIDs in physiological media. The physicochemical properties of LTTMs were characterized by state-of-art techniques commonly used for these systems. The cytotoxicity of G:S was also evaluated in L929 mouse fibroblasts and the viscosity, polarity, and pH properties of the studied mixtures were related to the solubility of NSAIDs. The pH and polarity were the parameters that most influenced the drugs’ solubility. Ibuprofen, naproxen, ketoprofen, indomethacin, and flurbiprofen did not present any solubility improvement in the formulations tested. However, concentrated mixtures of C:A:W or G:S in the physiologic-mimicked media (PBS) rendered a celecoxib solubility 4 and 5 times higher than PBS, respectively. These therapeutic liquid formulations of celecoxib in C:A:W or G:S can be a promising tool to increase celecoxib’s therapeutic efficiency in local applications.https://www.mdpi.com/1999-4923/13/10/1620LTTMNSAIDtherapeutic liquid formulationssolubilitycelecoxib
spellingShingle Ana Roda
Alexandre Paiva
Ana Rita C. Duarte
Therapeutic Liquid Formulations Based on Low Transition Temperature Mixtures for the Incorporation of Anti-Inflammatory Drugs
Pharmaceutics
LTTM
NSAID
therapeutic liquid formulations
solubility
celecoxib
title Therapeutic Liquid Formulations Based on Low Transition Temperature Mixtures for the Incorporation of Anti-Inflammatory Drugs
title_full Therapeutic Liquid Formulations Based on Low Transition Temperature Mixtures for the Incorporation of Anti-Inflammatory Drugs
title_fullStr Therapeutic Liquid Formulations Based on Low Transition Temperature Mixtures for the Incorporation of Anti-Inflammatory Drugs
title_full_unstemmed Therapeutic Liquid Formulations Based on Low Transition Temperature Mixtures for the Incorporation of Anti-Inflammatory Drugs
title_short Therapeutic Liquid Formulations Based on Low Transition Temperature Mixtures for the Incorporation of Anti-Inflammatory Drugs
title_sort therapeutic liquid formulations based on low transition temperature mixtures for the incorporation of anti inflammatory drugs
topic LTTM
NSAID
therapeutic liquid formulations
solubility
celecoxib
url https://www.mdpi.com/1999-4923/13/10/1620
work_keys_str_mv AT anaroda therapeuticliquidformulationsbasedonlowtransitiontemperaturemixturesfortheincorporationofantiinflammatorydrugs
AT alexandrepaiva therapeuticliquidformulationsbasedonlowtransitiontemperaturemixturesfortheincorporationofantiinflammatorydrugs
AT anaritacduarte therapeuticliquidformulationsbasedonlowtransitiontemperaturemixturesfortheincorporationofantiinflammatorydrugs